¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cis configuration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beam configuration
    ºö¹èÄ¡, ºö±¸Á¶, ºöÇüÅÂ
  • configuration
    1. À±°û, Çü»ó 2. ¹èÄ¡ 3. ±¸Á¶
  • cartwheel configuration
    ¼ö·¹¹ÙÄûÇü»ó
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü
  • electron configuration
    ÀüÀÚ¹èÄ¡
  • mitral configuration
    ½Â¸ðÆÇÇü»ó
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • configuration
    À±°û, Çü»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aortic configuration heart
    ´ëµ¿¸Æ¸ð¾ç½ÉÀå
  • beam configuration
    ºö¹èÄ¡, ºö±¸Á¶, ºöÇüÅÂ
  • configuration
    À±°û, Çü»ó
  • cartwheel configuration
    ¼ö·¹¹ÙÄûÇü»ó
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü
  • electron configuration
    ÀüÀÚ¹èÄ¡
  • lobulated configuration
    ¼Ò¿±Çü»ó
  • mitral configuration
    ½Â¸ðÆÇÇü»ó
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aortic configuration = sabot heart
    ´ëµ¿¸Æ(ÆÇ¸·Áúȯ) Çü»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-trans test
    ½Ã½º-Æ®·£½º°Ë»ç
  • aortic configuration = sabot heart
    ´ëµ¿¸Æ(ÆÇ¸·Áúȯ) Çü»ó
  • beam configuration
    ºö¹èÄ¡, ºö±¸Á¶, ºöÇüÅÂ
  • cartwheel configuration
    ¼ö·¹¹ÙÄû¸ð¾ç.
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü(¡­ïÈùêû¡).
  • configuration
    ¹èÄ¡(ÛÕöÇ), Çü»ó(û¡ßÒ), ±¸Á¶(ϰðã).
  • configuration
    Çü»ó, À±°û
  • electron configuration
    ÀüÀÚ¹èÄ¡(¡­ÛÕöÇ).
  • lobulated configuration
    ¼Ò¿± Çü»ó
  • mitral configuration
    ½Â¸ðÆÇÇüÅÂ(¡­û¡÷¾).
  • target configuration
    °ú³á ¸ð¾ç (Ç¥Àû¸ð¾ç)
  • target configuration
    °ú³á ¸ð¾ç (Ù¼åÆ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute configuration
    Àý´ëÀÔüÇü»ó±¸Á¶ (ï¾Óßí¡ô÷û¡ßÀϰðã)
  • cis-aconitic acid
    ½Ã½º-¾ÆÄÚ´ÏÆ¾»ê (ß«)
  • cis
    ½Ã½º
  • cis-acting locus
    ½Ã½ºÀÛ¿ë ºÎÀ§(íÂéÄÝ»êÈ)
  • cis-dominant
    ½Ã½º ¿ì¼º(éÐàõ)
  • cis effect
    ½Ã½º È¿°ú(üùÍý)
  • cis interactions
    ½Ã½º »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • cis isomer
    ½Ã½º À̼ºÃ¼(ì¶àõô÷)
  • cis-trans isomers
    ½Ã½ºÆ®¶õ½º À̼ºÃ¼(ì¶àõô÷)
  • cis-trans test
    ½Ã½ºÆ®¶õ½º ½ÃÇè(ãËúÐ)
  • configuration
    ÀÔüÇü»ó(Ø¡ô÷û¡ßÚ)
  • D-configuration
    D-ÀÔüÇü»ó(Ø¡ô÷û¡ßÚ)
  • erythro configuration
    ¿¡¸®Æ®·Î ÀÔüÇü»ó(Ø¡ô÷û¡ßÚ)
  • inversion of configuration
    ÀÔüÇü»ó ¹ÝÀü(Ø¡ô÷û¡ßÚÚãï®)
  • L-configuration
    LÀÔüÇü»ó(Ø¡ô÷úþßÚ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aortic configuration
    ´ëµ¿¸Æ(ÆÇ¸·Áúȯ)Çü»ó
  • cartwheel configuration
    ¼ö·¹¹ÙÄû¸ð¾ç
  • configuration
    Çü»ó, À±°û
  • lobulated configuration
    ¼Ò¿±Çü»ó
  • mitral configuration
    ½Â¸ðÆÇÇüÅÂ
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
abs conf absolute configuration
CFA colonization factor antigen; colony-forming assay; complement-fixing antibody; complete Freund's adj...
CAP Cyclophosphamide, Adriamycin(Doxorubicin), cis-Platinum
CIS Carcinoma In Situ
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
13-cis-RA 13 cis retinoic acid
9-cis-RA 9-Cis-retinoic acid
cis-DDP Cis-Dichlorodiammine platinum
Cis-DDP Cis-diaminedichloro-platinum
cis-DDP Cis-diamminedichloroplatinum II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cis-trans
    ½Ã½º-Æ®¶õ½º ½ÃÇè
    ¹Ì»ý¹° À¯ÀüÇп¡¼­, µ¿ÀÏÇÑ Ç¥ÇöÇü È¿°ú¸¦ °®´Â µÎ °¡Áö µ¹¿¬º¯À̰¡ µ¿ÀÏÇÑ À¯ÀüÀÚ³»¿¡ Á¸ÀçÇÏ´ÂÁö ¶Ç´Â ´Ù¸¥ À¯ÀüÀÚ¿¡ Á¸ÀçÇÏ´ÂÁö¸¦ ÆÇÁ¤ÇÏ´Â ½ÃÇè.
  • aortic configuration
    ´ëµ¿¸Æ Çü»ó, ´ëµ¿¸Æ ÆÇ¸· Áúȯ Çü»ó
  • chromosome configuration
    ¿°»öü Á¢ÇÕÇü
  • configuration
    Çü»ó, À±°û
  • electron configuration
    ÀüÀÚ ¹èÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
cis configuration <molecular biology> The configuration of an organic molecule containing a double bond between two carbon atoms, where the largest, most complex R groups are on the same side: H H \ / C=C / \ H3C CH3 -OR-The configuration of an organic molecule containing a ring, where the largest, most complex R groups are on the same side: H H | ___ \ / | // \\ [ring viewed edge-on] | \___/ / \ | /---\ H3C CH3 | H3C CH3.
A genetics term meaning an event or a gene whose action occurs on the same chromosome.
Two mutations in different genes coding for the same phenotype which are on the same chromosome (as opposed to the trans configuration where each homologue has one of the mutations).
Compare: trans configuration.
(11 Jan 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
3-carboxy-cis-cis-muconate cyclase <enzyme> Do not confuse with muconate cycloisomerase
Registry number: EC 5.5.1.5
Synonym: 3-carboxy-cis,cis-muconate lactonizing enzyme, 3-cmle, carboxy-cis,cis-muconate cyclase
(26 Jun 1999)
absolute configuration <chemistry> The three-dimensional arrangement of the atoms around the chiral centre of a molecule.
(09 Oct 1997)
configuration <chemistry> The three-dimensional arrangement of an organic molecule that is caused by: double bonds that prevent free rotation, or chiral centres that haveside groups arranged around them in a particular order.
A configurational isomer cannot be turned into another configuration without breaking covalent bonds.
(09 Oct 1997)
stereochemical configuration <chemistry> The arrangement of atoms in a molecule in three-dimensional space, especially with regard to the differences between enantiomers. The arrangements are specified in chemical formulas with the letters R, S, L, and/or D.
In the R, S system, each asymmetric carbon atom is classified as R (for rectus, Latin for right) if the chemical groups attached to it have decreasing priorities in a clockwise direction, or S (for sinister, Latin for left) if the chemical groups attached to it have decreasing priorities in a counterclockwise direction, when the carbon atom in question is viewed along the bond of the chemical group with the lowest priority. Priorities are assigned to chemical groups according to the Cahn-Ingold Prelog priority rules (generally, the larger the group the higher the priority).
L and D designations are given if the enantiomers have optical activity, that is, if they will rotate polarized light. The member of the pair which rotates polarized light clockwise is dextrorotatory, or D, and the member of the pair which rotates polarized light counterclockwise is levorotatory, or L (there is always one of each in every pair). This is also often referred to as handedness, where D is right-handed and L is lefthanded.
(13 Nov 1997)
degenerate configuration <radiobiology> Magnetic field configuration in which the magnetic lines of force close exactly on themselves after passing around the configuration a finite number of times.
(09 Oct 1997)
trans configuration 1. <chemistry> The configuration of an organic molecule containing a double bond between two carbon atoms, where the largest, most complex R groups attached to each carbon are on opposite sides.
Alternatively: The configuration of an organic molecule containing a ring, where the largest, most complex R groups attached to each carbon are on opposite sides.
These configurations are the opposite of cis configuration.
2. <genetics> A genetics term meaning that the changes in gene expression are due to something acting on the gene from a distance, or from an unrelated location, rather than on the same strand of DNA.
Two mutations in different genes coding for the same phenotype which are on opposite homologous chromosomes (as opposed to the cis configuration where both of the mutations are on the same homologue).
(17 Mar 1998)
field-reversed configuration <radiobiology> A compact torus produced in a theta pinch and having (in principle) no toroidal field. The potential advantages for a fusion reactor include a simple (linear) machine geometry, an average plasma pressure close to the confining field pressure, and physical separation of formation and burn chambers. The are predicted to be violently unstable to tilting, but this is rarely observed.
(09 Oct 1997)
peptidyl prolyl cis trans isomerase See: PPIase and immunophilin.
(18 Nov 1997)
CIS <abbreviation> Carcinoma in situ.
(05 Mar 2000)
cis- 1. <prefix> Prefix meaning on this side, on the near side; opposite of trans-.
2. <genetics> A prefix denoting the location of two or more genes on the same chromosome of a homologous pair, in coupling.
3. <chemistry> A form of geometric isomerism in which similar functional groups are attached on the same side of the plane that includes two adjacent, fixed carbon atoms (e.g., the 2-and 3-OH groups of ribofuranose) in a ring structure. Identical functional groups on the same side of the double bond are cis-. When the four moieties attached to the carbons of the double bond are all different, then the E/Z nomenclature has to be followed.
See: entgegen, zusammen.
Origin: L.
(20 Jun 2000)
cis-1,2-dihydrobenzene-1,2-diol dehydrogenase <enzyme> See also EC 1.3.1.20 (trans-1,2-dihydrobenzene-1,2-diol dehydrogenase; both enzymes catalyze the conversion of benzene dihydrodiol to catechol and may also have hydroxysteroid dehydrogenase activity
Chemical name: cis-1,2-dihydroxycyclohexa-3,5-diene (nad) oxidoreductase
Registry number: EC 1.3.1.19
Synonym: cis-benzene glycol dehydrogenase, cis-diol dehydrogenase, benzene dihydrodiol dehydrogenase, bedd gene product, nad+-dependent cis-benzene dihydrodiol dehydrogenase, todd gene product
(26 Jun 1999)
cis-3-chloroacrylic acid dehalogenase <enzyme> Specific for conversion of cis-3-chloroacrylic acid to muconic saemialdehyde (3-oxopropionic acid); 48 amino-terminal amino acid sequence given in first source
Registry number: EC 3.8.1.-
Synonym: cis-3caa dehalogenase
(26 Jun 1999)
cis-9,trans-11-octadecadienoate reductase <enzyme> Uses NADH and alpha-tocopherol quinol; forms trans-11-octadecenoate
Registry number: EC 1.3.1.-
Synonym: 9,11-ocdd reductase
(26 Jun 1999)
cis-aconitic acid Dehydration product of citric acid; an enzyme-bound intermediate in the tricarboxylic acid cycle.
(05 Mar 2000)
cis acting <molecular biology> Having to do with a genetic element (such as a promoter or other regulatory locus) having an effect (like promotion or suppression) on two unrelated targets (such as genes) on the same chromosome as a result of their relative positions on the chromosome.
A gene which regulates the transcription into mRNA of other genes nearby on the same chromosome by binding protein transcription factors which are necessary to turn transcription on or off.
(09 Oct 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
cis configuration Two sites on the same molecule of DNA.
Ãâó: depts.washington.edu/~genetics/courses/genet372/w2...
cis configuration Has the hydrogen atoms on the same side of the double bond, particularly with unsaturated fatty acids
Ãâó: webexhibits.org/butter/glossary-c.html
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • CIS
    Chemical Information System;communication interface system;Counter intelligence Service ´ë øº¸ºÎ
  • cis-
    ...ÀÇ ÀÌÂÊÀÇ ¶æ
  • configuration
    ¹è¿­
  • clean configuration
    ¼øÇ× ÇüÅÂ
  • configuration
    (ºÎºÐ.¿ä¼ÒÀÇ)»ó´ëÀû ¹èÄ¡;(ÁöÇ¥ µîÀÇ)Çü»ó;ÁöÇü;À±°û;¿ÜÇü;¼ºÀ§;(ºÐÀÚÀÇ)±¸¼º;¹è¿­;(·ÎÄÏÀÇ)Çü°ú ¹è¿­;~al();~ism ÇüÅ ½É¸®ÇÐ;configurative()
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á